These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7681843)

  • 1. Managing prostate cancer. Part I: Localized disease.
    Edelstein RA; Babayan RK
    Hosp Pract (Off Ed); 1993 Apr; 28(4):61-4, 68-70, 75-8. PubMed ID: 7681843
    [No Abstract]   [Full Text] [Related]  

  • 2. Treating prostate cancer, Part II: determining its severity.
    Harv Mens Health Watch; 2008 Jun; 12(11):1-4. PubMed ID: 18807624
    [No Abstract]   [Full Text] [Related]  

  • 3. [How to treat a localized prostate cancer: irradiation, surgery or watchful waiting?].
    Zellweger T; Gasser T
    Praxis (Bern 1994); 2005 Aug; 94(34):1307-8. PubMed ID: 16170999
    [No Abstract]   [Full Text] [Related]  

  • 4. Prostatic carcinoma.
    Lawton CA; Grignon D; Newhouse JH; Schellhammer PF; Kuban DA
    Radiographics; 1999; 19(1):185-203. PubMed ID: 9925399
    [No Abstract]   [Full Text] [Related]  

  • 5. [Tumor marker in prostate cancer].
    Arai Y
    Nihon Hinyokika Gakkai Zasshi; 1994 Nov; 85(11):1575-92. PubMed ID: 7528825
    [No Abstract]   [Full Text] [Related]  

  • 6. Editorial comment on: Insignificant prostate cancer and active surveillance: from definition to clinical implications.
    Albertson PC
    Eur Urol; 2009 Jun; 55(6):1331-2. PubMed ID: 19286304
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prostate cancer].
    Hefermehl L; Elke B; Sulser T
    Praxis (Bern 1994); 2010 Feb; 99(3):149-56, 158; quiz 157. PubMed ID: 20127633
    [No Abstract]   [Full Text] [Related]  

  • 8. Editorial comment on: Insignificant prostate cancer and active surveillance: from definition to clinical implications.
    Aus G
    Eur Urol; 2009 Jun; 55(6):1331. PubMed ID: 19286303
    [No Abstract]   [Full Text] [Related]  

  • 9. Prostate cancer testing.
    Med J Aust; 2000 May; 172(10):516. PubMed ID: 10901778
    [No Abstract]   [Full Text] [Related]  

  • 10. Prostate-specific antigen best practice policy--part II: prostate cancer staging and post-treatment follow-up.
    Carroll P; Coley C; McLeod D; Schellhammer P; Sweat G; Wasson J; Zietman A; Thompson I
    Urology; 2001 Feb; 57(2):225-9. PubMed ID: 11182325
    [No Abstract]   [Full Text] [Related]  

  • 11. Prostate specific antigen in the diagnosis and staging of prostate cancer.
    Jung P; Wolff JM; Mattelaer P; Jakse G
    Acta Urol Belg; 1996 Sep; 64(3):1-6. PubMed ID: 8946774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment for cancer specifically diagnosed in high-aged population, prostate cancer].
    Miki T
    Nihon Ronen Igakkai Zasshi; 2006 Jan; 43(1):71-3. PubMed ID: 16521807
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diagnosis and individualized therapy of locoregional prostate carcinoma].
    Wirth M; Fröhner M
    Urologe A; 2000 Nov; 39(6):578-87. PubMed ID: 11138282
    [No Abstract]   [Full Text] [Related]  

  • 14. Localized prostate cancer. Diagnosis and treatment.
    Bulbul MA
    J Med Liban; 1993; 41(4):218-22. PubMed ID: 7543154
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment strategy for prostate cancer].
    Kakehi Y
    Nihon Rinsho; 2002 Dec; 60 Suppl 11():170-6. PubMed ID: 12599566
    [No Abstract]   [Full Text] [Related]  

  • 16. The PSA: one test with three uses.
    Harv Mens Health Watch; 2001 Jul; 5(12):1-4. PubMed ID: 11511459
    [No Abstract]   [Full Text] [Related]  

  • 17. Favourable long-term outcomes with brachytherapy-based regimens in men ≤60 years with clinically localized prostate cancer.
    Edwards A; Laing R; Langley S
    BJU Int; 2013 Jun; 111(8):1181-2. PubMed ID: 23714643
    [No Abstract]   [Full Text] [Related]  

  • 18. [Not Available].
    Aktuelle Urol; 2014 Nov; 45(6):433. PubMed ID: 25514772
    [No Abstract]   [Full Text] [Related]  

  • 19. [Diagnosis and treatment of early-stage prostate carcinoma. Improved prognosis--fewer complications].
    Bastian PJ; Stief CG
    MMW Fortschr Med; 2010 May; 152(19):36. PubMed ID: 20556999
    [No Abstract]   [Full Text] [Related]  

  • 20. Case records of the Massachusetts General Hospital. Case 15-2008. A 55-year-old man with an elevated prostate-specific antigen level and early-stage prostate cancer.
    Barry MJ; Kaufman DS; Wu CL
    N Engl J Med; 2008 May; 358(20):2161-8. PubMed ID: 18480209
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.